4/A
Changes in Ownership
AYTU BIOPHARMA, INC Filed Acc 0001209191-16-139748
Options or other derivatives
- Chief Operating Officer bought 250,000 shares
From the SEC's structured data for this filing
Trades in this filing
Disbrow Jarrett · Chief Operating Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2016-05-06 | Purchase : show line 1 in the form Warrant to Purchase Common Stock | +250,000 | 250,000 | D |
Loading xslF345X03/doc4a.xml…